• Home>
  • Stocks>
  • Ind-Swift Laboratories Ltd Share Price
Ind-Swift Laboratories Ltd share price logo

Ind-Swift Laboratories Ltd Share Price

NSE: INDSWFTLAB

BSE: 532305

Small Cap

Healthcare Sector

₹92.88

-1.37

(-1.45%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Ind-Swift Laboratories Ltd Stock Performance

as on December 23, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹92.58
    ₹96.25
    downward going graph

    0.32%

    Downside

    3.63%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹68.72
    ₹124
    downward going graph

    26.01%

    Downside

    33.51%

    Upside

    downward going graph

Ind-Swift Laboratories Ltd share price movements today

Previous Close
₹94.25
Open
₹93.50
Volume
91.58K
Upper Circuit
₹113.10
Lower Circuit
₹75.40
Day's Low - High
₹92.58 - ₹96.25
52 Week Low - High
₹68.72 - ₹124

Ind-Swift Laboratories Ltd Historical Returns

1 Month Return
-1.54 %
3 Month Return
-9.29 %
1 Year Return
-12.97 %
3 Year Return
+ 48.89 %
5 Year Return
+ 61.8 %

Ind-Swift Laboratories Ltd Fundamentals

as on December 23, 2025 at 4:01 pm IST

Market Cap

₹769.19 Cr

Return on Equity (ROE)

0.64

PE Ratio (TTM)

2.74

Return on capital employed (ROCE)

1.09

Industry PE ratio

41.95

Beta (LTM)

0.85

P/B Ratio

0.53

Dividend Yield

0

PEG Ratio

-0.05

Quarterly Earnings Growth YOY

1910

EPS (TTM)

36.44

Sector

Pharmaceuticals

Book Value

159.86

Technical Analysis

Bearish

View Technical Analysis

Ind-Swift Laboratories Ltd Stock Valuation

as on December 23, 2025 at 4:01 pm IST

Ind-Swift Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-1795.00x)

December 8, 2022

Today (2.74x)

December 22, 2025

Industry (41.95x)

December 22, 2025

Highest (64.97x)

July 19, 2021

LowHigh

Today’s Price to Earnings Ratio: 2.74x

Ind-Swift Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Ind-Swift Laboratories Ltd image
Ind-Swift Laboratories Ltd
NA769.1912.36%0.52250561
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,346.64-1.95%0.7428311
Gland Pharma Ltd image
Gland Pharma Ltd
HOLD27,801.00-5.66%0.536985,616
Unichem Laboratories Ltd image
Unichem Laboratories Ltd
NA3,170.3716.17%0.581372,110
Tyche Industries Ltd image
Tyche Industries Ltd
NA115.36-9.23%0.001265
See all

Ind-Swift Laboratories Ltd Share Price Target

Get share price movements and forecasts by analysts on Ind-Swift Laboratories Ltd.

Source: S&P Global Market Intelligence

Ind-Swift Laboratories Ltd Stock’s Investor Sentiment and Interest

Search interest for Ind-Swift Laboratories Ltd Stock has increased by 37% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:37% versus previous 30 day period

Ind-Swift Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
312.69
304.25
310.34
289.71
287.51
528.57
33.17
11.96
124.66
138.24
152.73
152.64
Other Income
8.36
10.21
5.61
7.4
7.11
458.23
11.14
13.01
16.64
220.34
14.58
17.86
Total Income
321.04
314.45
315.94
297.11
294.63
986.8
44.31
24.96
141.29
358.57
167.32
170.5
Expenses
258.92
267.22
250.04
224.02
235.82
437.36
42.91
23.75
132.03
147.43
149.13
151.17
Operating Profit
53.77
37.03
60.3
65.69
51.69
91.21
-9.74
-11.79
-7.37
-9.19
3.6
1.47
Operating Profit Margin %
17.2%
12.17%
19.43%
22.67%
17.98%
17.26%
-29.36%
-98.58%
-5.91%
-6.65%
2.36%
0.96%
Profit Before Interest, Tax and Depreciation
62.12
47.23
65.91
73.09
58.8
549.44
1.4
1.21
9.26
211.14
18.18
19.34
Interest
22.38
21.82
20.38
21.14
21.05
2.96
0.17
0.41
10.03
-26.76
1.15
2.01
Depreciation
15.39
9.29
13.89
13.19
13.56
19.55
0.25
0.22
5.81
7.44
6.68
6.98
Profit Before Tax
24.35
16.12
31.64
38.76
24.19
526.93
0.98
0.58
-6.58
230.46
10.35
10.35
Tax Paid
-3.27
41.17
14.24
6.93
4.67
33.14
-0.03
0.18
-1.08
8.19
1.71
2.3
Profit After Tax
27.62
-25.05
17.4
31.83
19.53
493.79
1.01
0.4
-5.5
222.27
8.65
8.04
Total Net profit including share of profit / Loss from associate company
27.5
-25.13
17.25
31.65
19.42
493.67
0.94
0.41
-5.49
222.27
8.78
7.99
EPS
4.65
-4.25
2.92
5.36
3.29
83.55
0.16
0.07
-0.82
32.96
1.28
1
Actual EPS
4.65
-4.25
2.92
5.36
3.29
83.55
0.16
0.07
-0.82
32.96
1.28
1
Adjusted EPS
4.65
-4.25
2.92
5.36
3.29
83.55
0.16
0.07
-0.82
32.96
1.28
1
Diluted EPS
4.65
-4.25
2.92
5.36
3.29
83.55
0.16
0.07
-0.82
30.08
1.17
0.96

Ind-Swift Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
716.23
765.48
756.6
779.64
891.34
1,038.73
1,207.31
1,709.15
561.71
Other Income
20.72
18.38
119.84
33.4
22.7
43.5
33.5
479.35
304.59
Total Income
736.94
783.86
876.44
813.04
914.04
1,082.23
1,240.81
2,188.5
866.3
Expenses
615.62
633.11
630.52
635.26
708.52
843.11
1,004.76
1,406.09
581.1
Operating Profit
100.61
132.37
126.08
144.38
182.82
195.62
202.55
303.06
-19.39
Operating Profit Margin %
14.05%
17.29%
16.66%
18.52%
20.51%
18.83%
16.78%
17.73%
-3.45%
Profit Before Interest, Tax and Depreciation
121.32
150.75
245.93
177.78
205.52
239.12
236.05
782.41
285.2
Interest
88.37
28.21
92.2
107.49
100.22
95.55
92.17
103.78
2.92
Depreciation
88.26
86.62
104.05
90.06
87.29
131.04
57.36
80.41
24.48
Profit Before Tax
-55.31
35.92
49.68
-19.77
18.01
12.53
86.52
598.22
257.8
Tax Paid
-16.16
14.02
20.73
1.42
21.16
14.68
38.69
58.98
7.27
Profit After Tax
-39.13
21.92
28.95
-21.19
-3.15
-2.15
47.83
539.24
250.53
Total Net profit including share of profit / Loss from associate company
-39.13
21.92
28.95
-21.19
-3.15
-2.15
47.6
538.75
250.48
EPS
-9.2
4.86
-6.19
-4.28
-0.53
-0.36
8.06
91.18
37.25
Actual EPS
-9.2
4.86
-6.19
-4.28
-0.53
-0.36
8.06
91.18
37.25
Adjusted EPS
-9.2
4.86
-6.19
-4.28
-0.53
-0.36
8.06
91.18
37.25
Diluted EPS
-9.2
4.86
5.96
-4.28
-0.53
-0.36
8.06
91.18
35.21

Ind-Swift Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
79.43
95.57
73.09
-64.4
125.24
134.95
150.27
194.62
-186.98
-25.47
Cash Flow from Investing Activities
-28.77
-30.94
-17.4
-12.47
-9.1
-10.18
4.78
-13.37
-27.6
-110.2
Cash Flow from Financing Activities
-47.92
-68.9
-61.98
99.62
-133.26
-123.74
-140.88
-185.66
657.35
69.2
Net Cash Flow
2.74
-4.27
-6.3
22.76
-17.12
1.03
14.17
-4.41
442.77
-66.47

Ind-Swift Laboratories Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Ind-Swift Laboratories Ltd.

  • Ind-Swift Laboratories Ltd Earnings Results

    Ind-Swift Laboratories Ltd’s net profit jumped 1848.78% since last year same period to ₹7.99Cr in the Q2 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -8.89% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Ind-Swift Laboratories Ltd Dividends May,2011

    In the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 2.14%.

    Read More about Dividends

Insights on Ind-Swift Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 44.92% to 45.02% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 167.32 Cr → 170.5 Cr (in ₹), with an average increase of 1.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.2% return, outperforming this stock by 95.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 11.6% return, outperforming this stock by 24.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 39.50% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 222.27 Cr → 7.99 Cr (in ₹), with an average decrease of 52.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDSWFTLAB stock has moved down by -1.2%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 14.91% to 14.80% in Sep 2025 quarter

About Ind-Swift Laboratories Ltd

IndSwift Laboratories Ltd is an Indian based company that manufactures and sell Active Pharmaceutical Ingredients (API). Established in 1995, the company has grown to encompass 25 products, the most significant being Clarithromycin Macrolide antibiotic, Atorvastatin anticholestrol, Fexofenadine antihistamine, Clopidogrel anticholestrol, Nitazoxanide antidiarrheal, Pioglitazone antidiabetic, Letrozole and Anastrozole anticancer, Venlafaxine antidepressants, and Quetipine and Aripirazole antipsychotic. IndSwift Laboratories Ltd has built a strong presence in 40 plus countries, have a subsidiary in the USA, and set up a state of the art R&D Centre with a USD 5 million investment. Additionally, the production capacity has been increased to 418.18 TPA and its product portfolio continues to expand with compounds like Dutasteride, Cinacalcet, Duloxetine, Mecloxamine citrate, Atomoxetine, Exemestane, and more. In order to explore new opportunities in pharma, the company has entered joint ventures with Wellgen Medicare LLP and Mr. Anshul Jain, and Mr. Ramesh Mehta. As of now, the company has 3 subsidiaries - IndSwift Laboratories Inc in the US, Fortune India Constructions Limited in India, and Halcyon Life Sciences Pvt Ltd in India.

Revenue: ₹152.64Cr as on September 2025 (Q2 FY26)
Net Profit: ₹8.04Cr as on September 2025 (Q2 FY26)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
OrganisationInd-Swift Laboratories Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
CEON R Munjal
E-voting on sharesClick here to vote

FAQs

What is Ind-Swift Laboratories Ltd share price today?

Ind-Swift Laboratories Ltd share price today stands at ₹92.88 as on at the close of the market. Ind-Swift Laboratories Ltd share today touched a day high of ₹96.25 and a low of ₹92.58.

What is the 52 week high and 52 week low range for Ind-Swift Laboratories Ltd share?

Ind-Swift Laboratories Ltd touched a 52 week high of ₹124 and a 52 week low of ₹68.72. Ind-Swift Laboratories Ltd share price today i.e. is closed at ₹92.88, which is -25.10% down from its 52 week high and 35.16% up from its 52 week low.

What is Ind-Swift Laboratories Ltd's market capitalisation today?

Ind-Swift Laboratories Ltd market capitalisation is ₹769.19 Cr as on .

How to buy Ind-Swift Laboratories Ltd shares?

To buy Ind-Swift Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for INDSWFTLAB or Ind-Swift Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Ind-Swift Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Ind-Swift Laboratories Ltd trading volume today?

Ind-Swift Laboratories Ltd trading volume is 91.58K as on . This means that 91.58K shares of Ind-Swift Laboratories Ltd were bought and sold on the stock market during today's trading session.